Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.

Masao IwagamiRyosuke KumazawaYoshihisa MiyamotoYuri ItoMiho IshimaruKojiro MoritaShota HamadaNanako TamiyaHideo Yasunaga

Published in: Drug safety (2020)

We found no evidence that ranitidine/nizatidine is associated with an increased risk of cancer, although further studies with more accurate measurement of exposure, inclusion of older people, and longer follow-up may be needed.

Keyphrases

papillary thyroid
squamous cell
healthcare
high resolution
lymph node metastasis
squamous cell carcinoma
emergency department
big data
deep learning